Virocan Therapeutics Pvt
Business Services · India · 11-50 Employees
View Company Info for Free
Overview
Headquarters
402 Prakash Rao St, Vijayawada, Andhra P...Phone Number
+91 9290531709Website
www.virocan.comRevenue
<$5 MillionIndustry
About Virocan Therapeutics Pvt
Is Virocan Therapeutics Pvt your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Virocan Therapeutics Pvt
Click to see if Virocan Therapeutics Pvt had a recent Job posting/layoffs
Check if Virocan Therapeutics Pvt has recently received funding, and reach out quickly before it becomes old news!
Product Launch: Get notified when Virocan Therapeutics Pvt launches new products
Website visits: Recent activity has been detected on your website
Earning: See what the market has to say on Virocan Therapeutics Pvt recently announced quarterly report
Funding: Get notified immidiatlly once Virocan Therapeutics Pvt has new funding data
Virocan Therapeutics Pvt, which may be a good buyer, showed buying intent in Masked Content Topic
Check out if Virocan Therapeutics Pvt is spiking on competitors!
Recommended Actions
Find VP level buyers at Virocan Therapeutics Pvt
Find more new buyers
Company Profile Activity
Activity Insights
Virocan Therapeutics Pvt is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Virocan Therapeutics Pvt is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Virocan Therapeutics Pvt.
Virocan Therapeutics Pvt Tech Stack
A closer look at the technologies used by Virocan Therapeutics Pvt
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Virocan Therapeutics Pvt
Virocan Therapeutics Pvt. Ltd. is a privately held advanced biotechnology research and development company specializing in cancer-specific target identification, RNA inhibition, and immuno-gene therapy. The company focuses on the discovery of novel and biosimilar monoclonal antibodies and has a strong expertise in viral gene therapy and RNA interfe... Read More